Logotipo do repositório

CDH1 hypermethylation: A potential molecular pathway for invasiveness in glioblastoma

Carregando...
Imagem de Miniatura

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Wolters Kluwer

Tipo

Artigo

Direito de acesso

Acesso abertoAcesso Aberto

Resumo

Glioblastoma is the most aggressive central nervous system primary tumor. Prognosis is poor, mainly due to the malignant characteristics of the tumor, such as high cell proliferation and invasiveness. CDH1 hypermethylation is linked to the invasive potential in various cancer types, but its importance is still unknown in glioblastoma. In this context, the methylation status of CDH1 was analyzed using MSP-PCR (Methylation-specific Polymerase Chain Reaction) in glioblastoma (n = 34) and normal glial tissue samples (n = 11). CDH1 hypermethylation was found in 39.4% (13/34) of the tumor samples and none of the normal glial tissue, suggesting a relation between CDH1 hypermethylation and glioblastoma (P = 0.0195). Finally, this study showed unprecedented information that could contribute to clarifying the molecular pathways involved in the invasiveness and aggressiveness of this type of cancer.

Descrição

Idioma

Inglês

Citação

European Journal of Cancer Prevention, v. 33, n. 1, p. 73-75, 2024.

Financiadores

Publicações relacionadas

Unidades

Tipo de item:Unidade,
Botucatu, Faculdade de Medicina - FMB
FMB
Campus: Botucatu

Departamentos

Cursos de graduação

Programas de pós-graduação

Outras formas de acesso